Cell Banking Outsourcing Market Size, Share & Analysis Report, 2022-2030
The global Cell Banking Outsourcing market size was estimated at USD 9,869.5 million in 2021 and is expected to surpass around USD 35,593.6 million by 2030 and poised to grow at a compound annual growth rate (CAGR) of 16.40% during the forecast period 2022 to 2030.
Key Takeaways:
Rising advancement of the cryopreservation and cell banks preparation methodologies, increasing adoption of stem cell therapies, and growing demand for monoclonal antibodies along with effective biopharmaceuticals are the major factors, driving growth of the market. According to CellTrials.org global enrolments of new trials in advanced cell therapy were up almost 30% in the first quarter of 2020. Most of the rise can be associated to cell therapy efforts for treating COVID-19, and over half of those trials for COVID-19 employ umbilical cord MSCs. Hence, the pandemic has created a new market for those companies which are engaged in the manufacturing of MSCs products from donated birth tissues, hence may contribute to the market growth, post pandemic.
Moreover, many of these manufacturers have applied for COVID-19 EUA from the FDA and are partnering with local hospitals to treat COVID-19 patients. For instance, in September 2021, Life Cell’s Mesocel received approval for a clinical trial from DCGI; therapy derived MSC of the umbilical cord tissue set to treat patients with pneumonia, COVID-19, and acute respiratory distress.
The presence of favorable government initiatives for the development of stable cell lines, as well as the introduction of new technology for cell line storage and characterization, are among the critical factors expected to drive market growth in the forecast period. For instance, In December 2021, ‘Vineti’ and ‘Be The Match BioTherapies’ collaborated to develop an integrated supply chain management solution for gene and cell therapy. Such initiatives and collaborations are anticipated to drive growth during the forecast period.
Furthermore, the key players in the market are also involved in research collaborations, in order to reprogram newborn stem cells from umbilical cord blood as well as umbilical cord tissue into iPSCs. These collaborations are also expected to drive the growth of market over the forecast period. For instance, In May 2021, Opsis Therapeutics, FUJIFILM Cellular Dynamics, and Blue Rock Therapeutics entered into strategic research and development to create cell therapies to cure eye diseases. These companies will use their expertise to develop off-the-shelf iPSCs to cure ocular diseases.
According to a recent study led by the Indiana University School of Medicine in March 2022, human-induced pluripotent stem cells improve visual acuity and vascular health. This study is being done in collaboration with Indiana University School of Medicine and five other institutions to investigate a novel regenerative medicine approach to better manage the vascular health complications associated with type 2 diabetes. Such research activities are expected to boost stem cell banking. Additionally, research for the introduction of cry protective agents to preserve the stability of the tissues during cryopreservation is expected to drive the market.
Report Scope of the Cell Banking Outsourcing Market
|
Report Coverage |
Details |
|
Market Size |
US$ 35,593.6 million by 2030 |
|
Growth Rate |
CAGR of 16.40% from 2022 to 2030 |
|
Largest Market |
North America |
|
Fastest Growing Market |
Asia Pacific |
|
Base Year |
2021 |
|
Forecast Period |
2022 to 2030 |
|
Segments Covered |
Type, cell type, phase and Region, |
|
Companies Mentioned |
BioReliance, BioOutsource (Sartorious), BSL Bioservice, Cryo-Cell International, Inc, Charles River Laboratories, Covance, Global Stem Inc., Goodwin Biotechnology Inc., Lonza, SGS Life Sciences |
Type Insights
Master cell banking accounted for the largest share of revenue in 2021, as their preparation is a prerequisite for the production and usage of working cell banks. They are preserved for a significantly longer duration, which also attracts the application of high-grade cryopreservation methodologies and equipment thereby further expanding the revenue base for this segment.
Furthermore, master cell banks find applicability in various research and development perspectives for stem cell therapy and gene therapy. Rising incidences of autoimmune diseases and cancer that can be treated by the use of therapies in combination with regenerative medicine is a key factor expected to fuel the growth of this segment, during the forecast period.
Cell Type Insights
Stem cells segment dominated the market with a share of 55.4%in 2021. Stem cells are obtained from cord blood, embryonic, adult, dental, and IPS cells, while non-stem include somatic cells preserved for applications such as tissue engineering and IPS cell development. An increase in research and development activities associated with the applications of stem cells drives the segment growth. For instance, in February 2021, American CryoStem collaborated with BioTherapeutic Labs Corp for the research and development in stem cell.
Cord cell banking accounted significant market share with respect to revenue in 2021 and their large share can be attributed to the rise in the number of cord blood banks and banking services across the globe. Cord blood provides significant advantages, which include serving as a source of hematopoietic stem cells, donor convenience, minimized risk of graft versus host diseases, low risk of viral contamination and immediate availability.
Phase Insights
Based on phase, the market is segmented into bank storage, bank characterization and testing, and bank preparation. Of these, storage accounted for the largest share of revenue owing to sophisticated preservation needs which are essential for proper maintenance of either master or working banks. Additionally, technologically advanced cryopreservation techniques are expected to fuel the growth of this market throughout the forecast period.
Bank storage in cell banking encompasses the preservation of both master and working banking and their respective safety testing. Bank characterization & testing is expected to witness lucrative growth during the forecast period owing to the presence of market players that are involved in providing outsourcing services for bank characterization &testing to different hospitals and clinical research organizations. For instance, Creative Biogene offers a wide-ranging bank characterization service to the customers to safeguard the biosafety and control of biotechnological and biological products.
Regional Insights
North America dominated the market and accounted for the largest market share of 40.70%in 2021 owing to the presence of extensive R&D laboratories and rising incidences of metabolic disorders such as Parkinson’s, Alzheimer’s, and various other types of cancers, which can be treated by gene therapy. The steep rate of increase in the establishment of banking services, which is a sign of rapid change, also contributes to the organizational diversity in the North American healthcare system.
Asia Pacific is expected to grow at an exponential rate throughout the forecast period. This exponential CAGR is credited to the presence of pharmaceutical companies, which are focusing their priorities on the large and relatively untapped populations in Asia.
Low cost of clinical trials and high investments in biotechnology sector is expected to fuel the market growth of this regional market. In May 2022, International Conference on Stem Cell Research and Therapy was held in China, aiming to give a platform for academicians, researchers, industrial professionals to present their research and discuss developments, and advancements in stem cell. Such initiatives by private and government organizations to discuss and support stem cell research is anticipated to help the market grow in this region.
Some of the prominent players in the Cell Banking Outsourcing Market include:
Segments Covered in the Report
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2017 to 2030. For this study, Nova one advisor, Inc. has segmented the global Cell Banking Outsourcing market
By Geography
North America
Europe
Asia Pacific
Latin America
Middle East & Africa (MEA)
Key Points Covered in Cell Banking Outsourcing Market Study:
Chapter 1 Research Methodology
1.1 Market Segmentation & Scope
1.1.1 Estimates And Forecast Timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased Database
1.3.2 Nova one advisor’s Internal Database
1.3.3 Secondary Sources
1.3.4 Primary Research
1.3.5 Details Of Primary Research
1.4 Information or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis
1.6.1.1 Approach 1: Commodity flow approach
1.6.1.2 Approach 2: Country-wise market estimation using bottom-up approach
1.7 Global Market: CAGR Calculation
1.8 Research Assumptions
1.9 List of Secondary Sources
1.10 List of Primary Sources
1.11 Objectives
1.11.1 Objective 1:
1.11.2 Objective 2:
1.12 List of Abbreviations
Chapter 2 Market Definitions
Chapter 3 Executive Summary
3.1 Market Summary
Chapter 4 Global Cell Banking Outsourcing Market Variables, Trends, & Scope
4.1 Cell Banking Outsourcing Market Lineage Outlook
4.1.1 Parent Market Outlook
4.2 Penetration and Growth Prospect Mapping
4.3 Regulatory Framework
4.4 Market Driver Analysis
4.4.1 Technological Advancement Involving Cell Banking
4.4.2 Patent Expiration Of Blockbuster Biologics
4.4.3 Rising Demand For Monoclonal Antibodies
4.4.4 Growing R&D Investments In Biotechnology Sector
4.4.5 Increasing Prevalence Of Cancer
4.5 Market Restraint Analysis
4.5.1 Ethical Concern Related To Stem Cell Research
4.6 Porter’s Five Forces Analysis
Chapter 5 Cell Banking Outsourcing Market- Segment Analysis, by type, 2018 - 2030
5.1 Global Cell Banking Outsourcing Market: Type Movement Analysis
5.2 Master Cell Banking
5.2.1 Master Cell Banking market Estimates And Forecast, 2018 - 2030
5.3 Working Cell Banking
5.3.1 Working Cell Banking market Estimates And Forecast, 2018 - 2030
5.4 Viral Cell Banking
5.4.1 Viral Cell Banking Market Estimates And Forecast, 2018 - 2030
Chapter 6 Cell Banking Outsourcing Market- Segment Analysis, by Cell Type, 2018 - 2030
6.1 Global Cell Banking Outsourcing Market: Cell Type Movement Analysis
6.2 Stem Cell
6.2.1 Stem Cell market Estimates And Forecast, 2018 - 2030
6.2.2 Cord Cell Banking
6.2.2.1 Cord Cell Banking market estimates and forecasts, 2018 - 2030
6.2.3 Embryonic Stem Cell Banking
6.2.3.1 Embryonic Stem Cell Banking market estimates and forecasts, 2018 - 2030
6.2.4 Adult Stem Cell Banking
6.2.4.1 Adult Stem Cell Banking market estimates and forecasts, 2018 - 2030
6.2.5 Dental Stem Cell Banking
6.2.5.1 Dental Stem Cell Banking market estimates and forecasts, 2018 - 2030
6.2.6 IPS Stem Cell Banking
6.2.6.1 IPS Stem Cell Banking market estimates and forecasts, 2018 - 2030
6.3 Non-Stem Cell
6.3.1 Non-Stem Cell market Estimates And Forecast, 2018 - 2030
Chapter 7 Cell Banking Outsourcing Market- Segment Analysis, by Phase, 2018 - 2030
7.1 Cell Banking Outsourcing Market: Phase Movement Analysis
7.2 Bank Storage
7.2.1 Bank Storagemarket Estimates And Forecast, 2018 - 2030
7.2.2 Master Cell Bank Preparation
7.2.2.1 Master Cell Bank Preparation market estimates and forecasts, 2018 - 2030
7.2.3 Working Cell Bank Preparation
7.2.3.1 Working Cell Bank Preparation market estimates and forecasts, 2018 - 2030
7.2.4 Cell Storage Stability Testing
7.2.4.1 Cell Storage Stability Testing market estimates and forecasts, 2018 - 2030
7.3 Bank Characterization & Testing
7.3.1 Bank Characterization & Testing Market Estimates And Forecast, 2018 - 2030
7.3.2 Safety Testing
7.3.2.1 Safety Testing market estimates and forecasts, 2018 - 2030
7.3.2.1.1 Viral Cell Banks
7.3.2.1.1.1 Viral Cell Banks market estimates and forecasts, 2018 - 2030
7.3.2.2.1 Microbial Cell Banks
7.3.2.1.2.1 Microbial Cell Banks market estimates and forecasts, 2018 - 2030
7.3.3 Gene Expression Testing
7.3.3.1 Gene Expression Testing market estimates and forecasts, 2018 - 2030
7.3.4 Karyology Testing
7.3.4.1 Karyology Testing market estimates and forecasts, 2018 - 2030
7.3.5 Gene Sequencing Testing
7.3.5.1 Gene Sequencing Testing market estimates and forecasts, 2018 - 2030
7.4 Bank Preparation
7.4.1 Bank Preparationmarket Estimates And Forecast, 2018 - 2030
7.4.2 Master Cell Bank Preparation
7.4.2.1 Master Cell Bank Preparation market estimates and forecasts, 2018 - 2030
7.4.3 Working Cell Bank Preparation
7.4.3.1 Working Cell Bank Preparation market estimates and forecasts, 2018 - 2030
Chapter 8 Cell Banking Outsourcing Market: - Segment Analysis, by Region, 2018 - 2030
8.1 Cell Banking Outsourcing Market: Regional Movement Analysis
8.2 North America
8.2.1 North America Market Estimates And Forecast, 2018 - 2030
8.2.2 U.S.
8.2.2.1 U.S. market estimates and forecast, 2018-2030, USD Million
8.2.3 Canada
8.2.3.1 Canada Market Estimates And Forecast, 2018 - 2030
8.3 Europe
8.3.1 Europe Market Estimates And Forecast, 2018 - 2030
8.3.2 Uk
8.3.2.1 Uk Market Estimates And Forecast, 2018 - 2030
8.3.3. Germany
8.3.3.1 Germany Market Estimates And Forecast, 2018 - 2030
8.3.4 France
8.3.4.1 France Market Estimates And Forecast, 2018 - 2030
8.4 Asia Pacific
8.4.1 Asia Pacific market Estimates And Forecast, 2018 - 2030
8.4.2 Japan
8.4.2.1 Japan Market Estimates And Forecast, 2018 - 2030
8.4.3 China
8.4.3.1 China Market Estimates And Forecast, 2018 - 2030
8.4.4 India
8.4.4.1 India Market Estimates And Forecast, 2018-2030
8.4.5 Korea
8.4.5.1 Koreamarket Estimates And Forecast, 2018 - 2030
8.4.6 Singapore
8.4.6.1 Singapore market Estimates And Forecast, 2018 - 2030
8.5 Latin America
8.5.1 Latin America Market Estimates And Forecast, 2018 - 2030
8.5.2 Brazil
8.5.2.1 Brazil Market Estimates And Forecast, 2018 - 2030
8.5.3 Mexico
8.5.3.1 Mexico Market Estimates And Forecast, 2018 - 2030
8.6 Middle East & Africa (Mea)
8.6.1 Middle East & Africa Market Estimates And Forecast, 2018 - 2030
8.6.2 South Africa
8.6.2.1 South Africa Market Estimates And Forecast, 2018 - 2030
Chapter 9 Competitive Landscape
9.1 Public Companies
9.1.1 Company Market Position Analysis
9.1.2 Competitive Dashboard Analysis
9.1.3 Strategic Framework
9.2 Private Companies
9.2.1 List Of Key Emerging Companies/Technology Disruptors/Innovators
9.2.2 Regional Network Map
9.3 Company Profiles
9.3.1 BIORELIANCE
9.3.1.1 Company Overview
9.3.1.2 Financial Performance
9.3.1.3 Product Benchmarking
9.3.1.4 Strategic Initiatives
9.3.2 BIOOUTSOURCE (SARTORIOUS)
9.3.2.1 Company Overview
9.3.2.2 Financial Performance
9.3.2.3 Product Benchmarking
9.3.2.4 Strategic Initiatives
9.3.3 BSL BIOSERVICE
9.3.3.1 Company Overview
9.3.3.2 Financial Performance
9.3.3.3 Product Benchmarking
9.3.3.4 Strategic Initiatives
9.3.4 CRYO-CELL INTERNATIONAL, INC
9.3.4.1 Company Overview
9.3.4.2 Financial Performance
9.3.4.3 Product Benchmarking
9.3.4.4 Strategic Initiatives
9.3.5 CHARLES RIVER LABORATORIES
9.3.5.1 Company Overview
9.3.5.2 Financial Performance
9.3.5.3 Product Benchmarking
9.3.5.4 Strategic Initiatives
9.3.6 COVANCE
9.3.6.1 Company Overview
9.3.6.2 Financial Performance
9.3.6.3 Product Benchmarking
9.3.6.4 Strategic Initiatives
9.3.7 GLOBALSTEM INC.
9.3.7.1 Company Overview
9.3.7.2 Financial Performance
9.3.7.3 Product Benchmarking
9.3.7.4 Strategic Initiatives
9.3.8 GOODWIN BIOTECHNOLOGY INC
9.3.8.1 Company Overview
9.3.8.2 Financial Performance
9.3.8.3 Product Benchmarking
9.3.8.4 Strategic Initiatives
9.3.9 LONZA
9.3.9.1 Company Overview
9.3.9.2 Financial Performance
9.3.9.3 Product Benchmarking
9.3.9.3 Strategic Initiatives
9.3.10 SGS LIFE SCIENCES
9.3.10.1 Company Overview
9.3.10.2 Financial Performance
9.3.10.3 Product Benchmarking
9.3.10.4 Strategic Initiatives
Cross-segment Market Size and Analysis for Mentioned Segments
Additional Company Profiles
(Upto 5 With No Cost)
Additional Countries (Apart
From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market DynamicsRegion Level Market Share Import Export AnalysisProduction AnalysisOthers